login
  Password reminder

Subscribe Edit your account | View your account

Cardiovascular News

 Home | Latest News | Features | Profiles | Videos | Events | CVN ForumSupplements | Past Issues | Subscriptions

Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

Download past and current PDFs issues




 
1 - 20 of 29   Items
Cardiovascular News Issue 32 - February 2014
Cardiovascular News Issue 32 - February 2014
download now
Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by Ronald P Caputo -Profile: Ashok Seth
Cardiovascular News Issue 32 - February 2014 US Edition
Cardiovascular News Issue 32 - February 2014 US Edition
download now
Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by Ronald P Caputo -Profile: Ashok Seth
Cardiovascular News Issue 31 - October 2013
Cardiovascular News Issue 31 - October 2013
download now
Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be feasible when bilateral approach is not possible -Profile: Thomas F Luscher
Cardiovascular News Issue 31 - October 2013 US Edition
Cardiovascular News Issue 31 - October 2013 US Edition
download now
Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be feasible when bilateral approach is not possible -Profile: Thomas F Luscher
Cardiovascular News issue 30 - August 2013
Cardiovascular News issue 30 - August 2013
download now
Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in renal denervation by Erwin Blessing -Profile: Chaim Lotan
Cardiovascular News issue 30 - August 2013 US edition
Cardiovascular News issue 30 - August 2013 US edition
download now
Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in renal denervation by Erwin Blessing -Profile: Chaim Lotan
Cardiovascular News issue 29 - May 2013
Cardiovascular News issue 29 - May 2013
download now
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern
Cardiovascular News issue 29 - May 2013 US edition
Cardiovascular News issue 29 - May 2013 US edition
download now
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern
Cardiovascular News Issue 28 - February 2013
Cardiovascular News Issue 28 - February 2013
download now
Highlights: -RESPECT seen as positive despite failure to meet endpoint -Stent type may affect antiplatelet therapy duration -TAVI complications by Max Baghai -Profile: Stefan D Anker
Cardiovascular News Issue 28 - February 2013 US Edition
Cardiovascular News Issue 28 - February 2013 US Edition
download now
Highlights: -RESPECT seen as positive despite failure to meet endpoint -Stent type may affect antiplatelet therapy duration -TAVI complications by Max Baghai -Profile: Stefan D Anker
Cardiovascular News Issue 27 - October 2012
Cardiovascular News Issue 27 - October 2012
download now
Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with in-hospital mortality comparable to surgery -Profile: David Holmes
Cardiovascular News Issue 27 - October 2012 US edition
Cardiovascular News Issue 27 - October 2012 US edition
download now
Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with in-hospital mortality comparable to surgery -Profile: David Holmes
Cardiovascular News Issue 26 - August 2012 US edition
Cardiovascular News Issue 26 - August 2012 US edition
download now
Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy alone -Alain Cribier: 10 years of TAVI -Profile: Bernard Chevalier
Cardiovascular News Issue 26 - August 2012
Cardiovascular News Issue 26 - August 2012
download now
Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy alone -Alain Cribier: 10 years of TAVI -Profile: Bernard Chevalier
Cardiovascular News Issue 25 - May 2012
Cardiovascular News Issue 25 - May 2012
download now
Highlights: -TAVI as effective as surgery in high-risk patients at two years -Sustained blood pressure reduction achieved with renal denervation out to three years -MRI and arrhytmias by James White -Profile: John Ormiston
Cardiovascular News Issue 24 - February 2012 EU edition
Cardiovascular News Issue 24 - February 2012 EU edition
download now
Highlights:
-iFR vasodilator-free measure of stenosis severity comparable to FFR
-PARTNER A: Transfemoral TAVI improves quality of life, costs vs. surgery
-MRI safe in patients with selected cardiac rhythm management devices
-Profile: Jeffrey Moses
Cardiovascular News Issue 24 - February 2012 US edition
Cardiovascular News Issue 24 - February 2012 US edition
download now
Highlights:
-iFR vasodilator-free measure of stenosis severity comparable to FFR
-PARTNER A: Transfemoral TAVI improves quality of life, costs vs. surgery
-MRI safe in patients with selected cardiac rhythm management devices
-Profile: Jeffrey Moses
Cardiovascular News Issue 23 - November 2011
Cardiovascular News Issue 23 - November 2011
download now
Highlights:
-Lower thrombosis risk with newer generation drug-eluting stents
-Intra-aortic balloon counterpulsation does not appear to provide benefit
-"Prasugrel or ticagrelor should be administered to patients at clinical high risk for stent thrombosis"
-Profile: Ulrich Sigwart
Cardiovascular News Issue 22 - August 2011
Cardiovascular News Issue 22 - August 2011
download now
Highlights:
-FFR-CT technique can cut unnecessary coronary procedures
-"TAVI should be performed with cerebral protection"
-Pioneer of interventional cardiology in China receives Ethica Award 2011
-Profile: Martyn Thomas
Cardiovascular News Issue 21 - May 2011
Cardiovascular News Issue 21 - May 2011
download now
Highlights:
-PARTNER find TAVI as good as surgery
-Absorb shows positive one-year safety and efficacy results
-Profile: Ralph Brindis
Cardiovascular News Issue 20 - Feb 2011
Cardiovascular News Issue 20 - Feb 2011
download now
Highlights
- New absorbable stent era begins
- TAVI improves quality of life in inoperable patients
- Profile: Roberto Ferrari

Latest News





Features





Profiles






Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions